Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 362

1.

Common genetic polymorphisms of microRNA biogenesis pathway genes and risk of breast cancer: a case-control study in Korea.

Sung H, Lee KM, Choi JY, Han S, Lee JY, Li L, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D.

Breast Cancer Res Treat. 2011 Dec;130(3):939-51. doi: 10.1007/s10549-011-1656-2.

PMID:
21766210
2.

Common genetic polymorphisms of microRNA biogenesis pathway genes and breast cancer survival.

Sung H, Jeon S, Lee KM, Han S, Song M, Choi JY, Park SK, Yoo KY, Noh DY, Ahn SH, Kang D.

BMC Cancer. 2012 May 28;12:195. doi: 10.1186/1471-2407-12-195.

3.

CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.

Han S, Lee KM, Choi JY, Park SK, Lee JY, Lee JE, Noh DY, Ahn SH, Han W, Kim DH, Hong YC, Ha E, Yoo KY, Kang D.

Breast Cancer Res Treat. 2008 Jul;110(2):387-93.

PMID:
17940865
4.
5.

Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.

Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY.

J Biomed Sci. 2006 May;13(3):419-32.

PMID:
16502042
6.

Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.

Liang J, Chen P, Hu Z, Zhou X, Chen L, Li M, Wang Y, Tang J, Wang H, Shen H.

Carcinogenesis. 2008 Dec;29(12):2341-6. doi: 10.1093/carcin/bgn235.

7.

Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.

Han W, Woo JH, Yu JH, Lee MJ, Moon HG, Kang D, Noh DY.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):793-8. doi: 10.1158/1055-9965.EPI-10-1282.

9.

Genetic variants in trinucleotide repeat-containing 9 (TNRC9) are associated with risk of estrogen receptor positive breast cancer in a Chinese population.

Liang J, Chen P, Hu Z, Shen H, Wang F, Chen L, Li M, Tang J, Wang H, Shen H.

Breast Cancer Res Treat. 2010 Nov;124(1):237-41. doi: 10.1007/s10549-010-0809-z.

PMID:
20213080
10.

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.

11.

Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women.

Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Khuhaprema T, Yoshida T.

Breast Cancer Res Treat. 2010 Oct;123(3):885-93. doi: 10.1007/s10549-010-0804-4.

PMID:
20180013
12.

Fragment c gamma receptor gene polymorphisms and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians.

Iwasaki M, Shimada N, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Hamada GS, Nishimoto IN, Iyeyasu H, Motola J Jr, Laginha FM, Anzai R, Tsugane S.

Breast Cancer Res Treat. 2011 Apr;126(2):497-505. doi: 10.1007/s10549-010-1109-3.

PMID:
20697800
13.

Estrogen receptor genotypes and haplotypes associated with breast cancer risk.

Gold B, Kalush F, Bergeron J, Scott K, Mitra N, Wilson K, Ellis N, Huang H, Chen M, Lippert R, Halldorsson BV, Woodworth B, White T, Clark AG, Parl FF, Broder S, Dean M, Offit K.

Cancer Res. 2004 Dec 15;64(24):8891-900.

14.

Combined effects of antioxidant vitamin and NOS3 genetic polymorphisms on breast cancer risk in women.

Lee SA, Lee KM, Yoo KY, Noh DY, Ahn SH, Kang D.

Clin Nutr. 2012 Feb;31(1):93-8. doi: 10.1016/j.clnu.2011.08.005.

PMID:
21872972
15.

Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.

Yang H, Dinney CP, Ye Y, Zhu Y, Grossman HB, Wu X.

Cancer Res. 2008 Apr 1;68(7):2530-7. doi: 10.1158/0008-5472.CAN-07-5991.

16.

The role of polymorphisms in circadian pathway genes in breast tumorigenesis.

Dai H, Zhang L, Cao M, Song F, Zheng H, Zhu X, Wei Q, Zhang W, Chen K.

Breast Cancer Res Treat. 2011 Jun;127(2):531-40. doi: 10.1007/s10549-010-1231-2.

PMID:
20978934
17.

Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan.

Kawase T, Matsuo K, Suzuki T, Hirose K, Hosono S, Watanabe M, Inagaki M, Iwata H, Tanaka H, Tajima K.

Cancer Sci. 2010 May;101(5):1234-40. doi: 10.1111/j.1349-7006.2010.01496.x.

18.

Association of p53 genetic polymorphism (Arg72Pro) with estrogen receptor positive breast cancer risk in Japanese women.

Noma C, Miyoshi Y, Taguchi T, Tamaki Y, Noguchi S.

Cancer Lett. 2004 Jul 16;210(2):197-203. Erratum in: Cancer Lett. 2005 Sep 28;227(2):237.

PMID:
15183535
19.

Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.

Zheng SL, Zheng W, Chang BL, Shu XO, Cai Q, Yu H, Dai Q, Xu J, Gao YT.

Cancer Res. 2003 Nov 15;63(22):7624-9.

20.

[The XbaI and PvuII gene polymorphisms of the estrogen receptor alpha gene in Chinese women with breast cancer].

Lu X, Li B, Wei JM, Hua B.

Zhonghua Wai Ke Za Zhi. 2005 Mar 1;43(5):290-3. Chinese.

PMID:
15842934
Items per page

Supplemental Content

Support Center